➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Express Scripts
Dow
Boehringer Ingelheim
AstraZeneca

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Litigation Details for INDIVIOR INC. v. DR. REDDY'S LABORATORIES S.A. (D.N.J. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

INDIVIOR INC. v. DR. REDDY'S LABORATORIES S.A. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-09-14
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Kevin McNulty
Jury Demand None Referred To Cathy L. Waldor
Parties AQUESTIVE THERAPEUTICS, INC.; DR. REDDY'S LABORATORIES S.A.; DR. REDDY'S LABORATORIES, INC.; INDIVIOR INC.; INDIVIOR UK LIMITED
Patents 10,357,571; 10,377,824; 10,519,211; 7,579,326; 7,579,377; 7,659,254; 7,659,256; 7,772,243; 7,772,267; 7,931,212; 8,349,571; 8,603,514; 9,084,824; 9,296,687; 9,382,297; 9,579,305; 9,687,454; 9,849,118; 9,855,221; 9,931,305; 9,931,336; 9,931,357; 9,931,382
Attorneys AARON SCOTT ECKENTHAL; AMANDA LYN GENOVESE; CHARLES MICHAEL LIZZA; DAVID LEIGH MOSES; JAMIE L. LUCIA; KATHERINE HARIHAR; PHILIP SCOTT MAY; WILLIAM C. BATON; WILLIAM L. MENTLIK
Firms Lerner David Littenberg Krumholz and Mentlik LLP; Lerner, David, Littenberg, Krumholz & Mentlik, LLP; O'Melveny and Myers LLP; One CityCenter; Saul Ewing Arnstein & Lehr LLP; Steptoe & Johnson LLP; Troutman Sanders LLP
Link to Docket External link to docket
Small Molecule Drugs cited in INDIVIOR INC. v. DR. REDDY'S LABORATORIES S.A.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in INDIVIOR INC. v. DR. REDDY'S LABORATORIES S.A.

Details for INDIVIOR INC. v. DR. REDDY'S LABORATORIES S.A. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-07-13 123 Opinion December, 10, 2013, the Patent Office issued Patent No. 8,603,514 (“514 Patent”) for “Uniform Films for… the Patent Office. On April 3, 2018, the Patent Office issued Patent No. 9,931,305 (“305 Patent”) to … a continuation patent (known as the ‘305 patent”) granted to Aquestive by the Patent Office in April … 1163. The patents held by SimpleAir consisted of a parent patent and several child patents which all … parent patent, as well as the patent prosecution history, to see if the claims are patentably indistinct External link to document
2018-07-20 142 Opinion December, 10, 2013, the Patent Office issued Patent No. 8,603,514 (“‘514 Patent”) for “Uniform Films for… the Patent Office. On April 3, 2018, the Patent Office issued Patent No. 9,931,305 (“‘305 Patent”) to… a continuation patent (known as the ‘305 patent”) granted to Aquestive by the Patent Office in April … 1163. The patents held by SimpleAir consisted of a parent patent and several child patents which all … parent patent, as well as the patent prosecution history, to see if the claims are patentably indistinct External link to document
2018-12-12 207 Letter interpretation of the claim scope in U.S. Patent No. 9,931,305 (the “ ’305 Patent”) was one of the major disagreements…construction disputes between the parties on the ’305 Patent. However, as the schedule stands, the first…claim construction for certain terms of the ’305 Patent in light of the Federal Circuit’s opinion. Defendants…construction submissions with respect to the ’305 Patent. These duplicative efforts would burden the Court…September 2017 2:17-cv-07111-KM-CLW Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.